Customer satisfaction across the pharmacy sector is splitting sharply, with mail-order services rising while traditional retail pharmacies struggle to retain consumer confidence. The findings come from the J.D. Power 2026 U.S. Pharmacy
MoreBritish American Tobacco (BTI) serves as a stark warning that resolving enforcement actions with US authorities does not close the door on further legal exposure worldwide. Most corporations operating globally consider government
MoreThe United States is treating tokenization less as a speculative phenomenon and more as a fundamental redesign of how financial infrastructure operates at scale. Recent moves by U.S. regulators signal a shift
MoreLegal World Buzzes With Biglaw Hiring Rows, A Tupac Murder Trial, And A Drunk Official At McDonald’s
Biglaw firms are facing significant backlash over their push to recruit first-year law students at an extraordinarily early stage in their legal education. A judge has had their law license suspended after
MoreCoty Inc (COTY) is among a group of notable stocks trading lower in Thursday’s pre-market session following a mixed set of fourth-quarter results. The beauty and fragrance company’s latest quarterly figures failed
MoreThe North American Income Trust, trading on the London Stock Exchange under the ticker NAIT, has been added to the FTSE 250 Index, marking a significant milestone for the investment trust. Inclusion
MoreAmazon has confirmed it buys books through commercial channels after an investigation linked a bulk order of rare books to a facility where physical copies are reportedly destroyed and scanned. “Amazon purchases
MoreUltragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease type Ia. The FDA approved pariglasgene brecaparvovec-opnr, previously
MoreBoehringer Ingelheim has strengthened its position among the most respected companies in rare disease, building on significant gains recorded in the previous year’s survey. The German drugmaker climbed another four places in
MoreCMS Proposed Rule Threatens To Reshape Remote Patient Monitoring Industry With Sweeping Restrictions
Medicare’s remote patient monitoring framework, which launched in 2019, was designed to reimburse providers for tracking patient health data between office visits using home devices. In 2022, CMS expanded this framework by
More
